Search Press releases

Press releases teaser image
19 May 2026

BIMZELX[®](bimekizumab) demonstrates superior efficacy over SKYRIZI[®] (risankizumab) in psoriatic arthritis: BE BOLD Week 16 data

Read More
Press releases teaser image
7 May 2026

UCB, Cancer Research UK and Cancer Research Horizons announce new strategic alliance to accelerate development of novel cancer therapies

Read More
Press releases teaser image
3 May 2026

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Read More
Press releases teaser image
1 May 2026

UCB announces acquisition of IMIDomics’ Patient Insight Business, strengthening capabilities in immune-mediated inflammatory diseases (IMIDs)

Read More
Press releases teaser image
30 Apr 2026

UCB’s General Meeting of Shareholders 2026

Read More
Press releases teaser image
24 Apr 2026

Acquisition of own shares

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe